{"id":"https://openalex.org/W26760683","doi":null,"title":"Improving scFv stability through framework engineering","display_name":"Improving scFv stability through framework engineering","publication_year":2012,"publication_date":"2012-11-01","ids":{"openalex":"https://openalex.org/W26760683","mag":"26760683"},"language":"en","primary_location":{"id":"pmh:oai:ecommons.usask.ca:10388/ETD-2012-11-771","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10388/ETD-2012-11-771","pdf_url":null,"source":{"id":"https://openalex.org/S4377196608","display_name":"University Library - University of Saskatchewan (University of Saskatchewan)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I32625721","host_organization_name":"University of Saskatchewan","host_organization_lineage":["https://openalex.org/I32625721"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"thesis"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017357014","display_name":"Wayne Hill","orcid":"https://orcid.org/0000-0003-1455-9975","observed_orcids":["https://orcid.org/0000-0003-1455-9975"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Wayne Hill","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5017357014"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13326","display_name":"Biochemical and Structural Characterization","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/single-chain-variable-fragment","display_name":"scFv","score":0.953000009059906},{"id":"https://openalex.org/keywords/peptide-linkers","display_name":"peptide linkers","score":0.6449999809265137},{"id":"https://openalex.org/keywords/thermal-stability","display_name":"thermal stability","score":0.7860000133514404},{"id":"https://openalex.org/keywords/melting-point","display_name":"melting point","score":0.9070000052452087},{"id":"https://openalex.org/keywords/proline-mutations","display_name":"proline mutations","score":0.8820000290870667},{"id":"https://openalex.org/keywords/phage-display","display_name":"phage display","score":0.8059999942779541},{"id":"https://openalex.org/keywords/yeast-two-hybrid-screening","display_name":"yeast two-hybrid screening","score":0.8799999952316284},{"id":"https://openalex.org/keywords/hypervariable-region","display_name":"hypervariable region","score":0.9390000104904175},{"id":"https://openalex.org/keywords/k562-cells","display_name":"K562 cells","score":0.8119999766349792},{"id":"https://openalex.org/keywords/intracellular-stability","display_name":"intracellular stability","score":0.578000009059906},{"id":"https://openalex.org/keywords/antibody-fragments","display_name":"antibody fragments","score":0.4020000100135803}],"concepts":[{"id":"https://openalex.org/C36394416","wikidata":"https://www.wikidata.org/wiki/Q949267","display_name":"Immunoglobulin light chain","level":3,"score":0.5922921895980835},{"id":"https://openalex.org/C2780557392","wikidata":"https://www.wikidata.org/wiki/Q523796","display_name":"Linker","level":2,"score":0.5340313911437988},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5337610840797424},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5299656987190247},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5298271775245667},{"id":"https://openalex.org/C2776967038","wikidata":"https://www.wikidata.org/wiki/Q290671","display_name":"Single-chain variable fragment","level":4,"score":0.4946121871471405},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.4702312648296356},{"id":"https://openalex.org/C2779856020","wikidata":"https://www.wikidata.org/wiki/Q218642","display_name":"Alanine","level":3,"score":0.46782273054122925},{"id":"https://openalex.org/C147816474","wikidata":"https://www.wikidata.org/wiki/Q169525","display_name":"Protein engineering","level":3,"score":0.4479425251483917},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.38526421785354614},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.3829670548439026},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.36400890350341797},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3307204842567444},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2653854489326477},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2624273896217346},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.25616252422332764},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.21055728197097778},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.13631606101989746},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:ecommons.usask.ca:10388/ETD-2012-11-771","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10388/ETD-2012-11-771","pdf_url":null,"source":{"id":"https://openalex.org/S4377196608","display_name":"University Library - University of Saskatchewan (University of Saskatchewan)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I32625721","host_organization_name":"University of Saskatchewan","host_organization_lineage":["https://openalex.org/I32625721"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"thesis"},{"id":"pmh:oai:harvest.usask.ca:10388/ETD-2012-11-771","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/10388/ETD-2012-11-771","pdf_url":null,"source":{"id":"https://openalex.org/S7407063267","display_name":"HARVEST (University of Saskatchewan)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Thesis"},{"id":"mag:26760683","doi":null,"is_oa":false,"landing_page_url":"https://harvest.usask.ca/bitstream/10388/ETD-2012-11-771/3/HILL-THESIS.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.4000000059604645,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2924241358","display_name":"Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis","funder_award_id":"U01CA099168","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4907996376","display_name":"Avance II 500 High Performance Digital NMR Spectrometer System","funder_award_id":"S10RR024664","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G4985064185","display_name":"AVIII HD 400 NMR spectrometer to replace existing DRX 400","funder_award_id":"1s10od016360-01a1","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G6455051986","display_name":"Methods for Bioactive Compound Synthesis","funder_award_id":"R01GM077309","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G9000869322","display_name":"Kansas IDeA Network of Biomedical Research Excellence 5","funder_award_id":"P20GM103418","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"},{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":96,"referenced_works":["https://openalex.org/W60759546","https://openalex.org/W74992319","https://openalex.org/W1484092314","https://openalex.org/W1487803265","https://openalex.org/W1495321447","https://openalex.org/W1537235822","https://openalex.org/W1545752332","https://openalex.org/W1583405960","https://openalex.org/W1867971437","https://openalex.org/W1939186328","https://openalex.org/W1965692673","https://openalex.org/W1967334867","https://openalex.org/W1969190415","https://openalex.org/W1969328947","https://openalex.org/W1971900847","https://openalex.org/W1972084253","https://openalex.org/W1973974738","https://openalex.org/W1979142801","https://openalex.org/W1981718777","https://openalex.org/W1983494459","https://openalex.org/W1985468090","https://openalex.org/W1989639228","https://openalex.org/W1989672802","https://openalex.org/W1990789777","https://openalex.org/W1992244448","https://openalex.org/W1993575340","https://openalex.org/W1995304122","https://openalex.org/W1996820981","https://openalex.org/W1997300266","https://openalex.org/W1998267237","https://openalex.org/W2000106654","https://openalex.org/W2001210310","https://openalex.org/W2003381975","https://openalex.org/W2007731525","https://openalex.org/W2011261569","https://openalex.org/W2013128795","https://openalex.org/W2018008255","https://openalex.org/W2021188441","https://openalex.org/W2022228265","https://openalex.org/W2022807899","https://openalex.org/W2028284841","https://openalex.org/W2031594339","https://openalex.org/W2038591876","https://openalex.org/W2043627899","https://openalex.org/W2043917207","https://openalex.org/W2044154766","https://openalex.org/W2045401427","https://openalex.org/W2046737947","https://openalex.org/W2050602939","https://openalex.org/W2052708596","https://openalex.org/W2054086725","https://openalex.org/W2054592480","https://openalex.org/W2056368762","https://openalex.org/W2059347064","https://openalex.org/W2060204419","https://openalex.org/W2062558590","https://openalex.org/W2064509616","https://openalex.org/W2068635250","https://openalex.org/W2070360032","https://openalex.org/W2070576058","https://openalex.org/W2072948213","https://openalex.org/W2077392774","https://openalex.org/W2081728646","https://openalex.org/W2082874134","https://openalex.org/W2086959309","https://openalex.org/W2088046311","https://openalex.org/W2090028908","https://openalex.org/W2092079812","https://openalex.org/W2096003848","https://openalex.org/W2100837269","https://openalex.org/W2100892769","https://openalex.org/W2101327971","https://openalex.org/W2106892694","https://openalex.org/W2107409328","https://openalex.org/W2107429330","https://openalex.org/W2108053853","https://openalex.org/W2108315653","https://openalex.org/W2115648640","https://openalex.org/W2116506837","https://openalex.org/W2117061676","https://openalex.org/W2125787003","https://openalex.org/W2127061933","https://openalex.org/W2129150005","https://openalex.org/W2131988430","https://openalex.org/W2138712395","https://openalex.org/W2142402729","https://openalex.org/W2144258047","https://openalex.org/W2146799043","https://openalex.org/W2149156187","https://openalex.org/W2152458717","https://openalex.org/W2158078460","https://openalex.org/W2159581345","https://openalex.org/W2166726458","https://openalex.org/W2264620640","https://openalex.org/W2318264815","https://openalex.org/W2478761754"],"related_works":["https://openalex.org/W2022228265","https://openalex.org/W1761553731","https://openalex.org/W7100384171","https://openalex.org/W2158078460","https://openalex.org/W2079971222","https://openalex.org/W2154543415","https://openalex.org/W7220775917","https://openalex.org/W2235519817","https://openalex.org/W2414671909","https://openalex.org/W2415027739"],"abstract_inverted_index":{"The":[0,193],"availability":[1],"of":[2,13,19,31,57,73,88,105,109,112,123,144,189,205,303],"cost-effective":[3],"high":[4],"throughput":[5],"screening":[6],"assays":[7,281],"combined":[8],"with":[9,182,200],"an":[10,74],"enhanced":[11],"understanding":[12],"oncogenesis":[14],"has":[15],"driven":[16,54],"the":[17,29,55,71,103,110,132,142,149,190,206,226,245,265],"development":[18,56],"more":[20],"potent,":[21],"specific,":[22],"and":[23,37,48,65,91,152,159,176,213,235,242,249,264,278],"less":[24,198,202],"toxic":[25],"anti-cancer":[26],"agents.":[27],"At":[28],"forefront":[30],"these":[32],"advances":[33],"are":[34],"immunoglobulin":[35],"molecules":[36],"their":[38,119,250],"fragments.":[39],"However,":[40],"difficulties":[41],"in":[42,45,225,305],"producing":[43],"antibodies":[44,63],"sufficient":[46],"quantity":[47],"quality":[49],"for":[50,232],"commercial":[51],"application":[52],"have":[53],"alternative":[58],"systems":[59],"that":[60,164,188,204,289,309],"can":[61],"produce":[62],"efficiently":[64],"cost-effectively.":[66],"This":[67],"thesis":[68],"focuses":[69],"on":[70,287],"engineering":[72],"antibody":[75,89,114],"fragment":[76,84],"referred":[77],"to":[78,135,147,223,237,282,297],"as":[79],"a":[80,99,271],"single":[81],"chain":[82,93],"variable":[83,94,150,215,227],"(scFv),":[85],"which":[86],"consists":[87],"light":[90,151,212],"heavy":[92,153,214],"domains":[95,216],"fused":[96],"together":[97],"by":[98,217],"peptide":[100,167],"linker.":[101],"Although":[102],"use":[104],"scFvs":[106,163,196,243,288,304],"circumvents":[107],"many":[108],"issue":[111],"full-length":[113],"production,":[115],"they":[116],"still":[117],"possess":[118],"own":[120],"unique":[121],"set":[122],"difficulties,":[124],"including":[125],"stability.":[126,138,292],"In":[127],"this":[128,295],"thesis,":[129],"we":[130,140,210,269],"explored":[131],"following":[133],"strategies":[134],"increase":[136],"scFv":[137,262,312],"First,":[139],"increased":[141,180,290],"number":[143],"linkers":[145],"used":[146,294],"join":[148],"domains.":[154],"We":[155,293],"constructed":[156],"two":[157,160,194,310],"linear":[158,170],"cyclic":[161,195],"permutated":[162,171],"contained":[165],"additional":[166],"linkers.":[168],"Two":[169],"scFvs,":[172],"named":[173],"Model":[174,177],"1":[175],"3,":[178],"showed":[179],"stability":[181,252],"calculated":[183],"melting":[184],"temperatures":[185],"(Tms)":[186],"exceeding":[187],"unpermutated":[191,207],"scFv.":[192,208,267],"were":[197,240,247,256],"stable":[199],"Tms":[201],"than":[203],"Second,":[209],"mutated":[211],"introducing":[218],"prolines":[219],"or":[220],"mutating":[221],"glycine":[222,236],"alanine":[224,238],"domain":[228],"framework":[229],"regions.":[230],"Sites":[231],"proline":[233],"mutations":[234,239,246],"identified":[241],"containing":[244],"purified":[248,261],"thermal":[251],"tested.":[253],"Unfortunately,":[254],"there":[255],"no":[257],"discernible":[258],"differences":[259],"between":[260],"mutants":[263],"control":[266],"Third,":[268],"designed":[270],"new":[272],"selection/screening":[273],"strategy":[274,296],"using":[275],"phage":[276],"display":[277],"yeast":[279],"two-hybrid":[280],"identify":[283],"complementarity":[284],"determining":[285],"regions":[286],"intracellular":[291],"isolate":[298],"anti-Abl-SH3":[299,311],"scFvs.":[300],"Transient":[301],"expression":[302],"K562":[306],"cells":[307],"indicated":[308],"decreased":[313],"viability.":[314]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2016-06-24T00:00:00"}